Pharma CEO Pay Up In India, Ratio Versus Employee Earnings Glaring
Executive Summary
Pharma CEOs in India took home higher remuneration in 2017-18, with experts suggesting that the upward trend isn’t entirely unexpected. The huge CEO-to-employee pay ratios – over 600 in one case – isn’t a healthy trend, though.
You may also be interested in...
India CEO Pay: Local Firms Still Way Ahead Of Foreign Peers
CEOs of top Indian firms continue to earn more than their peers at leading multinational firms operating in the country and experts see limited prospects for a major change in pay structures at foreign firms, at least for now. Scrip brings you a snap-shot of CEO earnings at some leading Indian and foreign firms in 2016-17.
How Sanofi Is ‘Playing To Win’ In India, Watch Diabetes Space
Sanofi India managing director Rodolfo Hrosz talks to Scrip about the company’s refreshed India strategy including in the competitive diabetes segment, which is expected to see a flurry of new product activity. While Soliqua has hit the market, all eyes are also on Novo Nordisk’s Awiqli and Cipla’s partnered inhaled insulin in the wings.
Asia Deal Watch: Nippon Shinyaku Takes On Intractable Rare Disease With MiNA
Plus deals involving Incyte/CMS, Biocytogen/ABL, Bharat/Biofabri/Bilthoven, Dr. Reddy’s/Pharmazz, Veeda/Heads, Sosei Heptares/GSK, BioGeometry/Sanyou, Ono/Sibylla and Teijin/BioProjet